TCT-760 Treatment of Acquired von Willebrand Syndrome in Aortic Stenosis with Transcatheter Aortic Valve Replacement (TAVR)

Conclusions We describe a significant prevalence of aVWS in patients undergoing TAVR. Since severe factor deficiency can lead to significant bleeding during SAVR, TAVR should be taken into consideration as a first line treatment for patients with AVS and concomitant aVWS.

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2014-09, Vol.64 (11), p.B222-B222
Main Authors: Spangenberg, Tobias, Budde, Ulrich, Thomas, Thielsen, Frerker, Christian, Kuck, Karl-Heinz, Schäfer, Ulrich
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
Drug therapy
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Conclusions We describe a significant prevalence of aVWS in patients undergoing TAVR. Since severe factor deficiency can lead to significant bleeding during SAVR, TAVR should be taken into consideration as a first line treatment for patients with AVS and concomitant aVWS.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2014.07.832